GRI Total Utang marang Modal GRI Bio Corp

GRI (GRI Bio Corp) - tandha merek perusahaan

GRI Bio, Inc. (GRI) relies on external contractors for drug manufacturing and testing to avoid infrastructure costs. Research efficiency is being enhanced through the implementation of robotics in the creation of NKT inhibitors. Market price fluctuations on GURU.Markets reflect a total debt-to-equity ratio of 0.00, which is critical for this biotech ecosystem dependent on venture capital and stringent FDA oversight.

GRI Rasio Kabeh Utang marang Dana Pribadi GRI Bio (21.02.2024 - 28.10.2026)

Rincian analitis perusahaan GRI Bio, Inc.

- rega lan prakiraan konsensus rega:
Rega saham GRI Bio|GRI - Konsensus nilai wajar
- data kapitalisasi pasar:
Kapitalisasi pasar GRI Bio|GRI - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham GRI Bio|GRI - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku gribio.com|GRI - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal GRI Bio, Inc.|GRI - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas GRI Bio, Inc.|GRI - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku GRI Bio|GRI - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan GRI Bio
Analisis dhasar perusahaan:GRI Bio - GRI
Produk dadi gribio.com

This ratio measures the degree of financial leverage by comparing total liabilities to net assets to assess the business's dependence on external financing and default risks. Analyzing the proportion of total debt to equity reveals the extent to which the deployment of software robots and robotic molecule screening stations at GRI Bio, Inc. (GRI) relies on borrowed funds or internal resources.

Pesaing wigati

ARGX - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi BioNTech Inc.|Total Utang marang Modal ABVX|Total Utang marang Modal ADMA (ADMA Corp)|Utang marang Ekuitas Protagonist Therapeutics|immunovant.com - Rasio Kabeh Utang marang Dana Pribadi|KNSA: Utang marang Ekuitas|GRFS - Rasio Total Utang marang Ekuitas|ADPT: Total Utang marang Modal|Total Utang marang Modal Celldex Corp|AUPH - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi biocryst.com|VERA (Vera Therapeutics) - Total Utang marang Modal|Koefisien Total Utang marang Modal DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp - Utang marang Ekuitas|AbCellera - Rasio Total Utang marang Ekuitas|TRML: Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|PHAR: Rasio Total Utang marang Ekuitas|NKTR (Nektar Therapeutics Inc) - Total Utang marang Modal|Utang marang Ekuitas Upstream Bio Corp (UPB)|Rasio Utang marang Ekuitas Zenas Corp|Immunome, Inc. - Total Utang marang Modal|Utang marang Modal gossamerbio.com (GOSS)|KALV (KalVista Pharmaceuticals, Inc.) - Total Utang marang Modal|Septerna, Inc. - Rasio Utang marang Modal|Utang marang Ekuitas Pieris Pharmaceuticals Inc (PVLA)|SVRA - Rasio Kabeh Utang marang Dana Pribadi|Rigel Pharmaceuticals - Total Utang marang Modal|Koefisien Total Utang marang Modal anaptysbio.com|ATXS - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi enGene Holdings Inc|Total Utang marang Modal RAPT Therapeutics, Inc. (RAPT)|Utang marang Ekuitas aerovatetx.com (JBIO)|Total Utang marang Modal ACRS|kyvernatx.com - Koefisien Total Utang marang Modal|TLSA (Tiziana Life Sciences Ltd) - Utang marang Ekuitas|Cabaletta Bio Inc. (CABA) - Utang marang Modal|Rasio Total Utang marang Ekuitas Ventyx Bio VTYX|Theratechnologies, Inc (THTX) - Rasio Kabeh Utang marang Dana Pribadi|AVTX: Total Utang marang Modal|Koefisien Total Utang marang Modal ELDN|Utang marang Ekuitas Agenus Inc. AGEN|Rasio Utang marang Ekuitas Climb Bio Inc. (CLYM)|Zura Bio Limited - Total Utang marang Modal|ATYR - Rasio Total Utang marang Ekuitas|Rasio Total Utang marang Ekuitas ADAG (Adagene Corp)|IMA - Koefisien Total Utang marang Modal|Total Utang marang Modal STTK (shattucklabs.com)|EQ (Equillium) - Rasio Utang marang Modal|CNTB - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Immunic Inc|ATRA (Atara Biotherapeutics) - Total Utang marang Modal|Koefisien Total Utang marang Modal IFRX (inflarx.de)|X4 Pharmaceuticals, Inc. (XFOR) - Utang marang Ekuitas|Utang Agregat marang Ekuitas Adicet Bio Inc. ACET|Total Utang marang Modal Celularity Corp (CELU)|INMB - Rasio Kabeh Utang marang Dana Pribadi|BRNS: Total Utang marang Modal|KZR (kezarlifesciences.com) - Total Utang marang Modal|SABS - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi AKTX|Utang marang Ekuitas ENLV (Enlivex Therapeutics)|Rasio Total Utang marang Ekuitas q32bio.com (QTTB)|Total Utang marang Modal GOVX (GeoVax Labs, Inc.)|EDSA - Total Utang marang Modal|Rasio Total Utang marang Ekuitas iBio (IBIO)|CARM - Rasio Kabeh Utang marang Dana Pribadi|XTL Biopharmaceuticals, Ltd. - Total Utang marang Modal|BOLT (Bolt Biotherapeutics, Inc.) - Koefisien Total Utang marang Modal|Utang marang Ekuitas HCWB|Rasio Total Utang marang Ekuitas APVO|Utang marang Ekuitas AIM (AIM ImmunoTech)|Rasio Total Utang marang Ekuitas aditxt.com ADTX|Rasio Total Utang marang Ekuitas XRTX (XORTX)|Vyome Therapeutics - Total Utang marang Modal|Revelation Biosciences (REVB) - Utang marang Ekuitas|INDP - Rasio Utang marang Ekuitas|Total Utang marang Modal SCNI|CalciMedica (CALI) - Utang marang Modal|Affimed NV - Total Utang marang Modal|Rasio Utang marang Modal ALLK|HOOKIPA Pharma Inc. (HOOK) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi igmbio.com (IGMS)|Total Utang marang Modal ITOS|OCEA - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas TC BioPharm (Holdings) PLC (TCBP)|THRD - Rasio Kabeh Utang marang Dana Pribadi